Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Drugs|August 29, 2025
Systemic Therapy for Advanced Thyroid Cancer-New Personalized OptionsLeslie Cheng, Kate NewboldEndocrine-Related Cancer|July 31, 2025
Targeting RET in medullary thyroid cancerKate Newbold, Leslie ChengCurrent Opinion in Oncology|December 7, 2022
Molecular genotyping in medullary thyroid cancerKate NewboldEndocrine Oncology (Bristol, England)|March 12, 2025
Acute severe hypocalcaemia after initiation of a selective RET-inhibitor in medullary thyroid cancerLeslie Cheng, Syeda Khadijah Ghaznavi, Jessica Stevens, et al.Future Oncology (London, England)|June 16, 2015
Lenvatinib: a new option for the treatment of advanced iodine refractory differentiated thyroid cancer?Loredana Lorusso, Kate NewboldFrontiers in Endocrinology|December 7, 2017
Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid CancerDario Tumino, Francesco Frasca, Kate NewboldEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 21, 2011
Outcome of Pregnancy After Exposure to Radioiodine In UteroSteve Hyer, Brenda Pratt, Kate Newbold, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2010
Early and late toxicity of radioiodine therapy: detection and managementSteve L Hyer, Kate Newbold, Clive L HarmerCase Reports in Oncology|August 1, 2014
Epidermal growth factor mutation as a diagnostic and therapeutic target in metastatic poorly differentiated thyroid carcinoma: a case report and review of the literatureHazel Lote, Jaishree Bhosle, Khin Thway, et al.Thyroid : Official Journal of the American Thyroid Association|May 15, 2010
Familial nonmedullary thyroid cancer: a review of the geneticsAyesha Khan, James Smellie, Chris Nutting, et al.Pageof 9